MediWound Ltd.

NASDAQ:MDWD

Biotechnology

Healthcare
$13.61 -0.60%

-$0.09 today

Market cap
$175.71M
Beta
0.15
P/E (TTM)
-7.0
EPS (TTM)
-$2.03
52W Low $13.54High $21.26

Volume 0.17M

Average 0.09M

MDWD Total Liabilities

Everything the company owes to creditors and other parties.

MediWound Ltd.NASDAQ: MDWD

Total Liabilities · Q1 FY2026 · quarter ended Mar 2026

Total liabilities rises 2.2% from a year ago

Total liabilities stood at $38.56M at the end of Q1 FY2026, up 2.2% from a year earlier and up 12.3% from the prior quarter. Over 3 fiscal years it compounded at -4.2% a year.

Context

  • Total liabilities amounted to 48.2% of total assets at the end of Q1 FY2026, down 6.5 pp from a year earlier.
  • Total liabilities increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether total liabilities keeps rising in the next quarterly balance sheet after a +2.2% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$38.56M+12.3% QoQ
Last fiscal yearDec 2025
$34.33M-18.9% YoY
Year agoMar 2025
$37.74M+2.2% since
Total Liabilities past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+2.2%——
1 year-18.9%——
3-year CAGR-4.2%——
5-year CAGR——
10-year CAGR——

Total Liabilities history

USD · from the balance sheet

Latest · FY2025
34.33M USD
Year-over-year change
-18.9%
4-year CAGR
+9.0%

Total Liabilities vs competitors

How MDWD compares with its peers on the latest reported figures

  • Peers report in different currencies, so total liabilities is compared through growth and share of total assets rather than absolute size.
  • Its year-over-year change of +2.2% is the 7th highest of 10, against a peer median of +17.8%.
  • Total liabilities amounts to 48.2% of total assets for MDWD, versus a peer median of 16.0%.
MDWD Competitors
Total Liabilities for MDWD and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
RNACCartesian Therapeutics, Inc.Mar 2026$436.51M USD+1.3%+80.3%151.4%
IVAInventiva S.A.Dec 2025€277.91M EUR+23.2%+57.9%111.7%
OBIOOrchestra BioMed Holdings, Inc.Mar 2026$49.69M USD+17.8%+6.2%49.4%
IVVDInvivyd, Inc.Mar 2026$38.69M USD-22.0%+9.1%16.0%
MDWDMediWound Ltd.Mar 2026$38.56M USD+2.2%-4.2%48.2%
NTHINeonc Technologies Holdings, Inc.Mar 2026$16.56M USD-8.3%—497.3%
AARDAardvark Therapeutics, Inc. Common StockMar 2026$11.6M USD+83.1%-38.2%11.8%
TARAProtara Therapeutics, Inc.Mar 2026$10.72M USD+6.4%+5.2%5.6%
SLSSELLAS Life Sciences Group, Inc.Sep 2026$9.29M USD+56.7%-22.6%6.6%
EPRXEupraxia Pharmaceuticals Inc.Mar 2026$9.2M USD+318.0%-29.3%6.3%
Peer median (excluding MDWD) —+17.8%+5.7%16.0%

Competitors are the stored peer set for MDWD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents11.05M33.9M11.87M9.16M4.8M
Short-term Investments0029.68M34.01M48.34M
Net Receivables2.27M9.7M4.42M5.85M2.37M
Inventory1.2M1.96M2.85M2.69M4.09M
Other Current Assets0363K167K00
Total Current Assets14.95M45.84M49.7M52.16M59.96M
Property, Plant & Equipment (Net)4.03M3.58M15.93M20.8M25.79M
Goodwill00000
Intangible Assets297K231K165K99K33K
Long-term Investments469K364K490K439K467K
Tax Assets(469K)(364K)000
Other Non-current Assets(4.32M)(3.81M)183K00
Total Non-current Assets4.79M4.18M16.76M21.33M26.29M
Total Assets19.74M50.02M66.46M73.5M86.26M
Account Payables4.69M5.66M4.22M4.1M3.61M
Short-term Debt000418K623K
Tax Payables00000
Deferred Revenue543K63K24K12K0
Other Current Liabilities3.85M3.87M1.86M17.73M18.43M
Total Current Liabilities10.72M12.06M10.83M26.54M25.71M
Long-term Debt00000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)119K00736K0
Other Non-current Liabilities12.1M26.2M10.39M8.55M472K
Total Non-current Liabilities13.61M27.05M16.74M15.8M8.62M
Total Liabilities24.33M39.1M34.86M42.34M34.33M
Common Stock75K143K184K215K258K
Retained Earnings(148.51M)(168.11M)(174.82M)(205.05M)(228.93M)
Accumulated OCI(19K)(5K)(18K)(11K)(32K)
Other Stockholders Equity00000
Minority Interest00000
Total Equity(4.58M)10.91M31.6M31.15M43.63M
Total Debt1.39M846K6.35M6.93M8.77M
Net Debt(9.66M)(33.05M)(5.52M)(2.22M)3.98M

MediWound Ltd.

NASDAQ:MDWD

Intrinsic Alpha fair value

Locked

Current Price

$13.61

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.